Overview

A Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ Trastuzumab

Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
A Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ Trastuzumab
Phase:
N/A
Details
Lead Sponsor:
Henan Cancer Hospital